Literature DB >> 15752251

The role of tubulointerstitial inflammation.

Guoping Zheng1, Yiping Wang, Deepika Mahajan, Xiaohong Qin, Ying Wang, Yuanmin Wang, Stephen I Alexander, David C H Harris.   

Abstract

BACKGROUND: Exploration of the role of tubulointerstitial inflammation in experimental chronic renal disease (CRD) is an essential step to understanding and finding new treatments for human CRD. Adriamycin nephrosis (AN) is an experimental analogue of human focal glomerular sclerosis and tubulointerstitial inflammation.
METHODS: Using murine and rat AN, we have systematically investigated the pathogenic roles of chemokines, costimulatory molecules, and inflammatory cells, such as macrophages and effector and regulatory T lymphocytes. The profile of humoral and cellular mediators was studied in vitro and in vivo. The pathogenic significance of various factors was investigated by DNA vaccination, leukocyte reconstitution and depletion, retroviral transduction, and blockade with monoclonal antibodies.
RESULTS: Renal cortical and tubular cell CC-chemokines, including MCP-1, RANTES, and MIP-1alpha, were up-regulated via mediation of NFkappaB, and contributed to disease by attracting inflammatory cells into the interstitium. The role of these chemokines was confirmed by DNA vaccination. CD40-CD40L costimulation signals were involved in expansion and activation of the inflammatory infiltrate, whereas PD-1 signals were inhibitory, and CD28-B7 appeared to have a neutral effect. Macrophage and CD8+ T cells were shown to be effectors of injury, whereas CD4+CD25+ and gammadelta T cells acted as regulatory cells. FoxP3 transduction was able to convert naive T cells to CD4+CD25+ regulatory T cells.
CONCLUSION: There is a broad range of humoral and cellular factors involved in the pathogenesis of experimental CRD, some of which are potential targets for treatment of human CRD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752251     DOI: 10.1111/j.1523-1755.2005.09423.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  8 in total

1.  Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome.

Authors:  Tiffany R Keepers; Lisa K Gross; Tom G Obrig
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

Review 2.  Mechanisms of disease: regulation of RANTES (CCL5) in renal disease.

Authors:  Alan M Krensky; Yong-Tae Ahn
Journal:  Nat Clin Pract Nephrol       Date:  2007-03

3.  Dual effect of chemokine CCL7/MCP-3 in the development of renal tubulointerstitial fibrosis.

Authors:  Julien Gonzalez; Sofia Mouttalib; Christine Delage; Denis Calise; Jean-José Maoret; Jean-Philippe Pradère; Julie Klein; Bénédicte Buffin-Meyer; Betty Van der Veen; Israel F Charo; Peter Heeringa; Johan Duchene; Jean-Loup Bascands; Joost-Peter Schanstra
Journal:  Biochem Biophys Res Commun       Date:  2013-07-19       Impact factor: 3.575

4.  Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.

Authors:  Frank B Cortazar; Kristen A Marrone; Megan L Troxell; Kenneth M Ralto; Melanie P Hoenig; Julie R Brahmer; Dung T Le; Evan J Lipson; Ilya G Glezerman; Jedd Wolchok; Lynn D Cornell; Paul Feldman; Michael B Stokes; Sarah A Zapata; F Stephen Hodi; Patrick A Ott; Michifumi Yamashita; David E Leaf
Journal:  Kidney Int       Date:  2016-06-07       Impact factor: 10.612

5.  The inflammatory and normal transcriptome of mouse bladder detrusor and mucosa.

Authors:  Marcia R Saban; Helen L Hellmich; Mary Turner; Ngoc-Bich Nguyen; Rajanikanth Vadigepalli; David W Dyer; Robert E Hurst; Michael Centola; Ricardo Saban
Journal:  BMC Physiol       Date:  2006-01-18

Review 6.  Role of COX-2/mPGES-1/prostaglandin E2 cascade in kidney injury.

Authors:  Zhanjun Jia; Yue Zhang; Guixia Ding; Kristina Marie Heiney; Songming Huang; Aihua Zhang
Journal:  Mediators Inflamm       Date:  2015-02-01       Impact factor: 4.711

7.  Adenosine A2A receptor: a target for regulating renal interstitial fibrosis in obstructive nephropathy.

Authors:  Hang Xiao; Hai-Ying Shen; Wei Liu; Ren-Ping Xiong; Ping Li; Gang Meng; Nan Yang; Xing Chen; Liang-Yi Si; Yuan-Guo Zhou
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

8.  Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation.

Authors:  Jei-Wen Chang; Hsin-Lin Tsai; Chang-Wei Chen; Hui-Wen Yang; An-Hang Yang; Ling-Yu Yang; Paulus S Wang; Yee-Yung Ng; Teng-Lung Lin; Oscar K Lee
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.